BioSniper
Phase 3 Readout~month

Phase 3 Topline: Albumin in Acute Variceal Bleeding: A Randomized Controlled Trial: ALB-AVB Trial

May 31, 2026
Company
ENANTA PHARMACEUTICALS INC (ENTA)
Indication
Cirrhosis; Acute Variceal Bleeding

Other upcoming events for ENTA

Phase 2 StartPhase 2 Start: Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Z
Jul 1, 2026
Phase 1 StartPhase 1 Start: A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Jul 28, 2026
Phase 3 ReadoutPhase 3 Topline: A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-
Jul 31, 2026
Phase 3 ReadoutPhase 3 Topline: Comparison of Efficacy of Tranexamic Acid Versus Vasopressin in Blood Loss Among Placenta Previa Pat
Aug 31, 2026
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multicenter, Randomized, Placebo- and Active Comparator-Controlled Study Evaluating the E
Dec 18, 2026

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
ENTA OverviewPDUFA DatesPhase 3 Readouts
BioSniper

AI-Powered Biotech Data Intelligence Platform

Product

  • Pricing
  • FAQ

Resources

  • Event Calendar
  • PDUFA Calendar
  • AdCom Schedule
  • Blog
  • About
  • Data Methodology

Data & Tools

  • Cash Runway Calculator
  • Trial Success Rates
  • FDA Review Timelines
  • PDUFA Complete Guide
  • Reading FDA AdCom Results

Legal

  • Privacy Policy
  • Terms of Service
  • Refund Policy
  • Contact Us

BioSniper is a data analytics SaaS tool for research purposes only. It does not constitute professional advice of any kind. Users should independently verify data and make their own decisions.

© 2026 Biosniper All rights reserved.Payments powered by Paddle